Anthropic S-1: $216bn staff equity, $160bn ungranted

By Zak and the True Work Office team | Published: 18 November 2026 | Category: blog | 3 min read

Anthropic S-1: $216bn staff equity, $160bn ungranted

Key points
  • Anthropic's amended S-1 filing discloses employee options and restricted stock units worth about $216bn at the top of its IPO price range.
  • A further $160bn of shares remain ungranted, with 2.05 billion shares retained for future awards under the 2026 equity plan and share purchase plan.
  • The filing attributes the reserve to hiring competition, particularly in the San Francisco Bay Area.
  • Lockup terms were not covered, leaving the timing of future share supply unresolved.

Anthropic’s amended S-1 filing puts a number on a part of the business that rarely surfaces in public: the paper value of equity held by staff. Employee options and restricted stock units are disclosed at about $216bn at the top of the company’s IPO price range, and a further $160bn of shares remain ungranted. The offering covers 825 million shares at $70 to $78 under ticker ANT, with trading scheduled from 19 November.

Those figures need scale to mean anything. Staff hold 1.77 billion options at an average strike price of $2.91, alongside 1.07 billion unvested RSUs, while each of the seven co-founders is selling about $264m of stock. A $26bn private placement involving Google, Nvidia, AMD, Broadcom, Micron, Microsoft and TSMC, taken together with the greenshoe option, pushes the total raise beyond $100bn. At 31 October the company reported an $81bn revenue run rate and trailing twelve-month revenue per employee above $6.6m.

What the reserve signals

The ungranted pool is the more revealing disclosure. At roughly $160bn it exceeds the base offering, and the 2.05 billion shares retained under the 2026 equity plan and share purchase plan are justified in the filing by hiring competition, particularly in the San Francisco Bay Area. Staff equity also amounts to more than three times the value of the shares being sold at the same price range. Treated as an accountability document rather than a pitch, the filing makes a concrete point: compensation has become a claim on listed stock, so grants of shares are decisions that public markets can price and shareholders can contest.

Timing, by contrast, is left open. Lockup terms fell outside the coverage, so when future supply reaches the market remains unresolved, and a reserve set aside for hiring is not the same as hiring. A disclosure of this kind records an intention and a capacity; it does not record an outcome. Nor does it separate vested from unvested holdings cleanly, beyond confirming that 1.07 billion RSUs have yet to vest.

A practical consequence beyond the listing

For universities and public research institutions the effect is narrower but still real. They compete for the same researchers without any comparable instrument, and a pay gap denominated in convertible equity is likely to shape who stays in teaching and open research. That is a question about where expertise is retained, not about who wins commercially.

Whether a disclosure regime built for shareholders is adequate for judging whether these packages buy research or merely retention is the question the filing raises and leaves open.

Thefoundergazette’s report on Anthropic S-1 shows $216bn of staff equity and $160bn still to grant provides the source reporting for this article.

Frequently asked questions

How much equity does Anthropic's staff hold?

The amended filing discloses options and restricted stock units worth about $216bn at the top of the IPO price range, comprising 1.77 billion options at an average strike of $2.91 and 1.07 billion unvested RSUs.

Does the filing say when staff and founders can sell?

No. Lockup terms were not covered in the reporting, so the timing of future share supply is unresolved.

โ† Back to Blog